Tirzepatide Weight Loss
- All
- News
-
Lost 10 Kilos And Your Hair Too? Expert Explains The Weight-Loss Drug Side Effect Nobody Told You About
Weight-loss drugs like semaglutide and tirzepatide may lead to temporary hair fall due to rapid weight loss and nutritional gaps. Experts explain the science behind this side effect and how to prevent and reverse it safely.
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
Lost 10 Kilos And Your Hair Too? Expert Explains The Weight-Loss Drug Side Effect Nobody Told You About
Weight-loss drugs like semaglutide and tirzepatide may lead to temporary hair fall due to rapid weight loss and nutritional gaps. Experts explain the science behind this side effect and how to prevent and reverse it safely.
-
Drug Combination May Boost Weight Loss in Older Women, Study Finds
A retrospective study from Mayo Clinic and Wayne State University found that postmenopausal women combining tirzepatide with hormone therapy lost significantly more body weight than those using the drug alone, prompting calls for larger, controlled c
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
